125 Cambridgepark Drive Cambridge, MA 02140 +1 877.848.9903

Challenges are an inevitability when building a drug portfolio in the rare disease space, and patient finding is no doubt chief among them. Clinical trial recruitment is highly capital intensive,...

Though it’s not often discussed, often the most difficult aspect of bringing a drug to market is finding the right patient population. This is especially true with rare diseases, where patients...

Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic and Jennifer Beachell, Tricia Gooljarsingh PhD and Mary Lee Tjoa of Momenta Pharmaceutical,...

Select Category

February 21, 2020

IPM.ai Empowers Pharmaceutical Brands to Find Their Ideal Patients


Machine Learning and Artificial Intelligence Empowers life sciences companies to identify, engage and activate patients who could benefit from new therapies and modalities of careCAMBRIDGE, MA. –...

January 20, 2020

IPM.ai Expands Health Data Coverage to Over 300 Million Patients


Real world data sources further enhances the commercial value and scale of patient-centered analytics

June 1, 2019

Machine Learning Times IPM.ai Interview


In anticipation of their upcoming conference presentation at Predictive Analytics World for Healthcare Las Vegas, June 16-20, 2019, we asked Steve Lamb, Principal at IPM.ai and Dan Fisher, VP Life...

May 21, 2019

Using AI and Real World Data to Do What’s Right for Patients


Driving Optimal Outcomes through the Use of Artificial Intelligence and Real World Data